Mizuho senior analyst Graig Suvannavejh joins BiotechTV for Analyst Thursdays from Kendall Square

Gene therapy experts TJ Cradick and Kate Excoffon discuss using AAV gene therapy for cystic fibrosis

Vedanta Biosciences founder and CEO Bernat Olle shares an expert take on microbiome drug development

Flagship's ProFound Therapeutics is searching for proteins for use as therapeutics and targets beyond those found in the traditional protein coding regions of DNA

Vor Bio is trying to help AML patients who receive a stem cell transplant to be more amenable to follow-on therapies - they just had key PoC data

Biotech lab technologies expert Bob Gantzer talks about the digital lab book, rovers, and future technologies still to come in biotech

Mathai Mammen provides an update on the latest at FogPharma, and his philosophy of following the cadence of science, not the calendar

Seattle based Shape Therapeutics is aiming to reprogram cells by delivering guide RNAs via AAV - it has partnerships with Otsuka and Roche

Dyno Therapeutics is using AI to develop next generation AAV vectors for gene therapies

Benchling Co-Founder and CEO Sajith Wickramasekara kicks off Benchtalk 2024 and highlights new feature announcements for this software platform that powers the biotech sector

Immuno-Oncology experts Zhen Su and Kristen Hege discuss the latest in the field and preview #SITC24

ARS Pharmaceuticals recently received FDA approval for neffy, epinephrine in a nasal spray format for the treatment of allergic reactions like anaphylaxis

Innovation Day San Diego: Palm Therapeutics is focused on developing palmitoylation targeted therapies

Innovation Day San Diego: The director of UCSD's Center for RNA Technologies and Therapeutics shares his thoughts on the RNA field

Innovation Day San Diego: The founder of San Diego based Resolute Science describes how the company aims to use macrophages to deliver toxic payloads to tumors

Houston Oncology Summit: The Cancer Focus Fund is closing on its second fund - it's a unique model that helps companies with knowhow and trial support at MD Anderson

Houston Oncology Summit: MD Anderson's Chief Data & Analytics Officer describes the impact of the digitization of medicine

Houston Oncology Summit: Oppenheimer analysts Jeff Jones and Jay Olson talk radiopharmaceuticals and antibody-drug conjugates

Houston Oncology Summit: MD Anderson Professor of Immunology Michael Curran talks turning cold tumors hot, including work by his company ImmunoGenesis

Houston Oncology Summit: Oppenheimer analyst Matt Biegler discusses the breast cancer space and learnings from the conference